[VIVO] YoY Quarter Result on 30-Sep-2016 [#Q4]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
29-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q4]
Profit Trend
QoQ- -37.27%
YoY- -35.15%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 50,846 53,100 49,697 46,998 47,068 46,692 48,962 0.63%
PBT 5,356 6,878 8,634 8,752 13,138 12,174 13,056 -13.79%
Tax 1,253 1,444 2,908 3,261 4,671 3,992 3,906 -17.25%
NP 4,103 5,434 5,726 5,491 8,467 8,182 9,150 -12.50%
Tax Rate -23.39% -20.99% -33.68% -37.26% -35.55% -32.79% -29.92% -
Total Cost 46,743 47,666 43,971 41,507 38,601 38,510 39,812 2.70%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 8.07 10.23 11.52 11.68 17.99 17.52 18.69 -13.05%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS 0.10 0.13 0.14 0.13 0.20 0.20 0.22 -12.30%
EPS Diluted 0.10 0.13 0.13 0.13 0.20 0.20 0.22 -12.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.